Sanofi-Aventis Czech Republic's total assets reached CZK 3,210 mil at the end of 2017, up 12.1% compared to the previous year.
Current assets amounted to CZK 3,075 mil, or 95.8% of total assets while cash stood at CZK 0.719 mil at the end of 2017.
By contrast, total debt reached CZK 775 mil at the year-end, or 24.1% of total assets, while the firm's equity amounted to CZK 752 mil. As a result, net debt stood at CZK 774 mil at the end of 2017 and accounted for 103% of equity.
Net debt against equity is down 130 pp from five years ago (232%). The ratio against EBITDA decreased from 16.5x seen in 2012 to 15.3x.
The company’s cost of funding amounted to 0.748% in 2017, down 0.054 pp compared to the average over the last 5 years.
You can see all the company’s data at Sanofi-Aventis Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
